The Technical Analyst
Select Language :
Abeona Therapeutics Inc [ABEO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Abeona Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Abeona Therapeutics Inc is listed at the  Exchange

-1.23% $7.25

America/New_York / 28 mar 2024 @ 16:00


Abeona Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 198.32 mill
EPS: -2.53
P/E: -2.87
Earnings Date: May 08, 2024
SharesOutstanding: 27.36 mill
Avg Daily Volume: 0.344 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/a
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.87 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.49x
Company: PE -2.87 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-0.709
(-109.78%) $-7.96
Date: 2024-03-28
Expected Trading Range (DAY)

$ 6.63 - 7.87

( +/- 8.61%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Vazzano Joseph Walter Sell 703 Common stock
2024-03-04 O'malley Brendan M. Sell 183 Common stock
2024-02-06 Seshadri Vishwas Buy 20 000 Common Stock
2024-01-17 Alvino Mark Sell 7 084 Common Stock
2023-10-16 Seshadri Vishwas Sell 181 Common Stock
INSIDER POWER
81.16
Last 95 transactions
Buy: 4 747 231 | Sell: 745 827

Forecast: 16:00 - $7.27

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $7.27
Forecast 2: 16:00 - $7.27
Forecast 3: 16:00 - $7.27
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $7.25 (-1.23% )
Volume 0.267 mill
Avg. Vol. 0.344 mill
% of Avg. Vol 77.71 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Abeona Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Abeona Therapeutics Inc

RSI

Intraday RSI14 chart for Abeona Therapeutics Inc

Last 10 Buy & Sell Signals For ABEO

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:30buy$5.34N/AActive
Profile picture for
            Abeona Therapeutics Inc

ABEO

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.

Last 10 Buy Signals

Date Signal @
RLCUSDMar 28 - 17:02$4.01
PSGUSDMar 28 - 17:015.30
TOMOUSDMar 28 - 14:10$1.091
FARMUSDMar 28 - 17:0153.54
MEDIAUSDMar 28 - 16:5823.37
ICXUSDMar 28 - 16:56$0.361
ROSEUSDMar 28 - 16:55$0.141
APTUSDMar 28 - 16:5017.00
BIFIUSDMar 28 - 16:48445.95
WSTETHUSDMar 28 - 16:494 124.37

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.